Barclays upgraded CVS Health Inc (NYSE:CVS) on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by ...

CVS Health (CVS) stock gained as Barclays upgraded the company, citing a compelling path to margin recovery in its Medicare ...

The U.S. government on Thursday announced quality ratings for 2025 Medicare health and prescription drug plans, the first ...

Medicare Advantage plans are changing their quality ratings, with the Centers for Medicare & Medicaid Services (CMS) ...

Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...

CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health ...

Discover why TD Cowen sees 35% upside in CVS Health stock, driven by Medicare Advantage improvements and bullish technical ...

CVS Health (CVS) stock receives an upgrade from TD Cowen to Buy with a price target of $85, based on favorable Medicare ...

Read More Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by ...

CVS Health and Cigna on Tuesday released details on their government-backed health insurance plans for next year for people ...

CVS Health is laying off nearly 3,000 "primarily corporate roles" in a cost-cutting move, the company confirmed to USA TODAY ...